Abstract:The ocular surface is the outermost part of the visual system that faces many extrinsic or intrinsic threats, such as chemical burn, infectious pathogens, thermal injury, Stevens-Johnson syndrome, ocular pemphegoid, and other autoimmune diseases. The cornea plays an important role in conducting light into the eyes and protecting intraocular structures. Several ocular surface diseases will lead to the neovascularization or conjunctivalization of corneal epithelium, leaving opacified optical media. It is believed that some corneal limbal cells may present stem cell-like properties and are capable of regenerating corneal epithelium. Therefore, cultivation of limbal cells and reconstruction of the ocular surface with these limbal cell grafts have attracted tremendous interest in the past few years. Currently, stem cells are found to potentiate regenerative medicine by their capability of differentiation into multiple lineage cells. Among these, the most common cell sources for clinical use are embryonic, adult, and induced stem cells. Different stem cells have varied specific advantages and limitations for in vivo and in vitro expansion. Other than ocular surface diseases, culture and transplantation of corneal endothelial cells is another major issue for corneal decompensation and awaits further studies to find out comprehensive solutions dealing with nonregenerative corneal endothelium. Recently, studies of in vitro endothelium culture and ρ-associated kinase (ROCK) inhibitor have gained encouraging results. Some clinical trials have already been finished and achieved remarkable vision recovery. Finally, nanotechnology has shown great improvement in ocular drug delivery systems during the past two decades. Strategies to reconstruct the ocular surface could combine with nanoparticles to facilitate wound healing, drug delivery, and even neovascularization inhibition. In this review article, we summarized the major advances of corneal limbal stem cells, limbal stem cell deficiency, corneal endothelial cell culture/transplantation, and application of nanotechnology on ocular surface reconstruction. We also illustrated potential applications of current knowledge for the future treatment of ocular surface diseases.

Stem cell therapy in ocular pathologies in the past 20 years

Regenerative treatment of ophthalmic diseases with stem cells: Principles, progress, and challenges

Stem cell-based therapies for retinal diseases: focus on clinical trials and future prospects

Potential therapeutic applications of mesenchymal stem cells for the treatment of eye diseases

Stem Cells And Ocular Tissue Regeneration

Stem/progenitor cells and biodegradable scaffolds in the treatment of retinal degenerative diseases.

New Perspectives in Stem Cell Transplantation and Associated Therapies to Treat Retinal Diseases: From Gene Editing to 3D Bioprinting

The current study, challenges and application of stem cell transplantation in ophthalmology

Ocular Stem Cell Research from Basic Science to Clinical Application: A Report from Zhongshan Ophthalmic Center Ocular Stem Cell Symposium

Adult stem cells in the eye: Identification, characterisation, and therapeutic application in ocular regeneration – A review

Exploring Stem-Cell-Based Therapies for Retinal Regeneration

The advancement of the study in retinal disease treatment with stem cells therapy

The Future of Stem Cells and Their Derivates in the Treatment of Glaucoma. A Critical Point of View

Research Advances on Stem Cells Therapy for Common Ocular Diseases

Innovative Bioscaffolds in Stem Cell and Regenerative Therapies for Corneal Pathologies

Ex-vivo ocular surface stem cell therapies: current techniques, applications, hurdles and future directions

Perspectives of stem cell research in ophthalmology

Stem Cell Therapy for Corneal Regeneration Medicine and Contemporary Nanomedicine for Corneal Disorders

Cell Replacement Therapy for Retinal and Optic Nerve Diseases: Cell Sources, Clinical Trials and Challenges

Cell therapy for retinal disease

Advances in stem cell research and therapeutic development